Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World Practice.

Title : Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World Practice

Source : PubMed
ID : 26330533
Authors : Mitchell AP, Harrison MR, Walker MS, George DJ, Abernethy AP, Hirsch BR
Year : 2015
Disease Category : Cancer
Focused Population : Not Specified
Priori/Posteriori : Both
Single-study Generalibility? : Multiple
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : Yes
Trial participants vs. general population (from EHR, survey, a cohort, etc) : Yes
Real-world data sources : a retrospective registry composed of academic (Duke) and community (ACORN Network) practices
Target Population Data Type Levels : Regional